PharmaTalkRadio

Conference Forum Director Valerie Bowling and CRAACO Producer Danny McCarthy break down what to expect at the 2025 CRAACO program. This podcast covers the keynotes, panels and key themes for this year's event, including:  How to develop a clinical research program within a community cancer center, with Dr Brian Slomovitz, Mount Sinai Medical Center Miami Beach Turning clinical environments into le...

PODD: Partnership Opportunities in Drug Delivery Directors Valerie Bowling and Andrew Goldstein break down what to expect at PODD 2025. This podcast covers keynotes and key themes for this year's event, including: Regeneron Co-Founder and CSO, Dr George Yancopoulos Novo Nordisk Chief Scientific Advisor, Dr Lotte Bjerre Knudsen MIT's Robert Langer Patient Keynote, Jimi Olaghere Northeastern Univers...

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can best support their regulatory teams and engage with the FDA and other regulators. Specifically, the panelists address: Engaging with the FDA on a peer-to-peer level Effectively negotiating about innovative approaches that may be outside of guidelines How...

This podcast features a panel discussion from the 2024 PODD Conference with biopharma leaders about biomaterial approaches to develop implants that can deliver molecules and optimize for dose frequency. Specifically: Defining biocompatible materials and biomaterials Differences between small and larger molecules Benefits and challenges of implants To learn more about the PODD conference, please vi...

Summary: The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operatio...

Summary: Mizuho Securities Analyst, Dr Graig Suvannavejh, joined the 2025 Immuno-Oncology 360º Summit to share an outlook on the IO biotech market, high-level thoughts on the IO space, and public IO company case studies to illustrate the market's perception of what's happening in IO.  More specifically: The current tailwinds working for and headwinds working against investment in biotech The incre...

In this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part II of this podcast series covers the 16 Pharma from the Trenches track case studies.

In this podcast series, DPHARM Directors Tracey Kimball and Valerie Bowling break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including: Former Merck CEO, Ken Frazier Former Head of FDA, Scott Gottlieb CRISPR Gene Therapy Patient Keynote, Victoria Gray Tuft's Ken Getz How DPHARM is tackling AI What to do about Protocol Com...

About this podcast:  Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience  on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community con...

This podcast features a panel discussion from the 2024 PODD Conference with pharma, medtech and academic leaders about technological development and patient and clinical adoption of closed-loop systems. Specifically: Success in diabetes and lessons for other indications like oncology and CNS New frontiers in improving closed-loop therapies Increasing access across therapy areas To learn more about...

Patient-reported outcomes (PROs) are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how to incorporate PROs into clinical trials in ways that improve probabilities of success while avoiding common mistakes. Specificall...

Summary: This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability.  The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be...

Summary: In this podcast from the 2024 CRAACO: Clinical Research as a Care Option conference, Dr Meredith Zozus, UT Health San Antonio, walks through several studies illustrating differences in data quality and scalability using EHRs in the conduct of structured protoocls versus retrospective studies using EHR. The results highlight the important methods and approaches for using EHR data in clinic...

Summary: This podcast delves into the critical challenges of scalability in T-cell therapies (including CAR-T, TILs, and TCR-T). The panelists discuss the primary obstacles hindering the increased availability of T-cell therapies to patients, the most promising upcoming approaches to enhance access, the greatest opportunities to improve efficiencies and scalability, and the developments in the nea...

Summary: This podcast focuses on the current state of patient centricity within the biopharmaceutical industry, how it's being implemented, operationalized and scaled within organizations, and showing the tangible value of engaging patients.  Dr Matthew Reaney,  Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, to share...

Summary: In this podcast, recorded at the 2025 Patients as Partners in Clinical Research conference, patient advocate and caregiver Dr Justin Hopkin, University of Rochester, describes his family's journey before, during and after his son was diagnosed with a rare, life-threatening disease.  Dr Hopkin talks about the process of getting a diagnosis, the critical role of a clinical trial for his son...

Summary: This podcast, recorded at the 2025 Immuno-Oncology 360º (IO360º) Summit, explores the clinical and market implications of emerging data on bispecific antibodies targeting PD-1 and VEGF and their potential to disrupt existing immunotherapy paradigms. More specifically:  Assessing the potential of this therapeutic approach to challenge established treatments like pembrolizumab by targeting...

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about approaches and challenges in developing sustained release and long acting injectable formulations of therapeutics. Specifically: Contrasting approaches for both biologics and small molecules Next generation technologies to provide less frequent administration Scalable and sustainable ways t...

Summary:  In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.  For more information, go to DPH...

Summary:  New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical care settings, and more.  In this session, recorded at the 2024 CRAACO: Clinical Research as a Care Option conference, Joan Chambers of the Tufts Cente...

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about formulation and physical approaches to achieve targeted brain delivery. The panelists discuss challenges and updates, patient acceptability and recent approvals for a variety of approaches including: Nose-to-brain delivery Introcerebroventricular injections Blood-brain-barrier disruption vi...

Summary:  This podcast covers how a co-creation and collaboration was formed between Abbott, the National Blood Clot Alliance and Luminous to gather qualitative insights exploring motivations in a key patient population for participating in clinical research.  The podcast additionally covers how the partnership has influenced patient engagement in a large healthcare organization, the resulting shi...

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about the technical innovation in the vaccine space within R&D over the past several years as well as the challenges and opportunities around the uptake and implementation of these technologies. Specifically: Barriers to implementation of technological advancements How the vaccine marketplace...

Summary: In this podcast, PALADIN Consortium Committee Co-Chairs, Deirdre BeVard of CSL and Dr Len Valentino of World Federation of Hemophilia USA, discuss how the pre-competitive group is creating resources aimed at enhancing and speeding up industry-patient advocacy collaborations.  For more information on PharmaTalk Radio podcasts, you can go to theconferenceforum.org . For more information on...

CMOs play a critical role in ensuring activities prior to approval lead to a successful launch. In this podcast, originally recorded as a session at the 2024 CMO Summit 360°, panelists discuss the role of the CMO in preparing for a new product launch, including planning, timing, activities and hiring prior to PDUFA, including: The timing and strategy of building out medical affairs Strategic imper...